<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04875312</url>
  </required_header>
  <id_info>
    <org_study_id>012/003187</org_study_id>
    <nct_id>NCT04875312</nct_id>
  </id_info>
  <brief_title>Effect of UC Versus EA on Sex Hormones in Obese Infertile Patients With PCOs</brief_title>
  <official_title>Effect of Ultrasound Cavitation Versus Electro Acupuncture on Sex Hormones in Obese Infertile Patients With Polycystic Ovarian Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mohamed Abdel Hamid elgaedy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the difference between the effect of Ultrasound&#xD;
      Cavitation and Elctroacupuncture on sex hormones in obese infertile patients with poly cystic&#xD;
      ovarian syndrome …………………………………………………………………… BACKGROUND: Polycystic ovary syndrome (PCOS) is a&#xD;
      common endocrine and metabolic disorder that occurs in 6 - 10% of women at the reproductive&#xD;
      age. It is associated with an-ovulation, infertility, hyperandrogenism, obesity and insulin&#xD;
      resistance.&#xD;
&#xD;
      Endocrine characteristics of PCOS are elevated serum concentrations of androgens and&#xD;
      Luteinizing hormone (LH) and decreased concentrations of sex hormone binding globulin (SHBG).&#xD;
&#xD;
      Ultrasound cavitation is the method in handling Subcutaneous Adipose Tissue (, especially in&#xD;
      destroying subcutaneous fat and shaping a particular part of the body. As one of the&#xD;
      non-surgical correction method, UC is preferred for lowering the risk of complications due to&#xD;
      obesity.&#xD;
&#xD;
      UC reported a greater decrease of the WHR, suggesting a valuable modification of fat&#xD;
      distribution pattern, especially at the abdominal level. It improves rates of ovulation,&#xD;
      provides higher incidence of regular menstrual cycles and lower levels of total testosterone.&#xD;
&#xD;
      Acupuncture is a treatment method used in Traditional Chinese Medicine. Electroacupuncture&#xD;
      promotes follicle development and corrects reproductive endocrine dysfunction in ovaries by&#xD;
      regulating the functions of the hypothalamus, pituitary and ovaries&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be designed as prospective, randomized, single blind, experimental, pre-post&#xD;
      test , controlled- trial study.&#xD;
&#xD;
      Simple Size Calculation:&#xD;
&#xD;
      I- Subjects:&#xD;
&#xD;
      Forty obese infertile patients with poly cystic ovarian syndrome will participate in this&#xD;
      study to determine the difference between the effect of Ultrasound Cavitation and&#xD;
      Elctroacupuncture on sex hormones. They will be selected randomly from Out Patient Clinic of&#xD;
      Aga Hospital Central, in Aga. All patients will be divided randomly into two equal groups&#xD;
      (A&amp;B).&#xD;
&#xD;
      Group A:&#xD;
&#xD;
      twenty obese infertile patients with PCO who will be treated by ultrasound cavitation, 2&#xD;
      times per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day)&#xD;
&#xD;
      Group B:&#xD;
&#xD;
      twenty obese infertile patients with PCO who will be treated by electroacupuncture, 3 times&#xD;
      per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day) II-&#xD;
      Instrumentations:&#xD;
&#xD;
        1. Recording data sheet (Appendix II).&#xD;
&#xD;
        2. Standard weight height scale: measure BMI&#xD;
&#xD;
        3. Tape measurement: measure waist/hip ratio.&#xD;
&#xD;
        4. Test tubes: used to collect the blood samples from obese infertile patients&#xD;
&#xD;
        5. Kites: used for assessment of serum progesterone level, testosterone, LH and FSH.&#xD;
&#xD;
        6. Abdominal ultrasongraphy: measure ovulation rate.&#xD;
&#xD;
        7. cavitation in group A 8- electroacupuncture in group B&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 30, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>weight</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>It will be use weight scale to measure weight to calculate the body mass index (BMI) for each woman.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>waist/hip ratio:</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>It will be use tape measurement to calculate the waist/hip ratio.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Testosterone hormones :</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>They will be use kites for assessment of level of testosterone hormones</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FSH Hormone</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>They will be use kites for assessment of level of FSH hormones</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lh hormones</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>They will be use kites for assessment of level of LH hormones</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Progesterone hormones</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>They will be use kites for assessment of level of progesterone hormones</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Height</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>It will be use tape measurement to measure height to calculate the body mass index (BMI) for each woman.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ovulation rate</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>It will be use ultrasonography for measuring ovulation rate.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>Group USC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Effect of ultrasound cavitation sessions on sex hormones in obese infertile patients with poly cystic ovarian syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group EA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Effect of electro acupuncture on sex hormones in obese infertile patients with poly cystic ovarian syndrome</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound cavitation in group A</intervention_name>
    <description>Group A:&#xD;
twenty obese infertile patients with PCO who will be treated by ultrasound cavitation, 2 times per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day)</description>
    <arm_group_label>Group USC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electro acupuncture in group B</intervention_name>
    <description>Group B:&#xD;
twenty obese infertile patients with PCO who will be treated by electroacupuncture, 3 times per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day)</description>
    <arm_group_label>Group EA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Their ages will be ranged between 20-35 year old.&#xD;
&#xD;
          2. Their body mass index will be ranged from 30-40 kg/m2.&#xD;
&#xD;
          3. All of them are married women.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women will be excluded if they have one of the following criteria:&#xD;
&#xD;
               1. Diabetes mellitus.&#xD;
&#xD;
               2. Thyroid dysfunction.&#xD;
&#xD;
               3. Concomitant cardiovascular disorders.&#xD;
&#xD;
               4. Respiratory, renal and liver dysfunction.&#xD;
&#xD;
               5. Tubal adhesions as well as uterine abnormalities.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>MANAL Ahmed El Shafei Mohamed, Lecturer</last_name>
    <phone>201220664518</phone>
    <email>Manalpt1989@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohamed Abdel Hamid El gaedy, Master</last_name>
    <phone>+20 109 943 0782</phone>
    <email>dr.mohamed_elgaedy@yahoo.com</email>
  </overall_contact_backup>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 19, 2021</study_first_submitted>
  <study_first_submitted_qc>May 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2021</study_first_posted>
  <last_update_submitted>May 5, 2021</last_update_submitted>
  <last_update_submitted_qc>May 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mohamed Abdel Hamid elgaedy</investigator_full_name>
    <investigator_title>Head OF physical therapy in AGA hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>From may 2021 to may 2022</ipd_time_frame>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 22, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/12/NCT04875312/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

